Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS Trial. by Josse, R, Majumdar, S, Zheng, Y, Adler, A, Bethel, M, Buse, J, Green, J, Kaufman, K, Rodbard, H, Tankova, T, Westerhout, C, Peterson, E, Holman, R, Armstrong, P

Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: Outcomes from TECOS. by Cornel, J, Bakris, G, Stevens, S, Alvarsson, M, Bax, W, Chuang, L, Engel, S, Lopes, R, McGuire, D, Riefflin, A, Rodbard, H, Sinay, I, Tankova, T, Wainstein, J, Peterson, E, Holman, R